Found: 5
Select item for more details and to access through your institution.
I-MIBG Therapy in metastatic phaeochromocytoma and paraganglioma.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2008, v. 35, n. 4, p. 725, doi. 10.1007/s00259-007-0652-6
- By:
- Publication type:
- Article
Potentiation of anti-cancer drug activity at low intratumoral pH induced by the mitochondrial inhibitor m-iodobenzylguanidine (MIBG) and its analogue benzylguanidine (BG).
- Published in:
- British Journal of Cancer, 1999, v. 79, n. 5/6, p. 793, doi. 10.1038/sj.bjc.6690127
- By:
- Publication type:
- Article
Bioavailability and toxicity after oral administration of m-iodobenzylguanidine (MIBG).
- Published in:
- British Journal of Cancer, 1999, v. 79, n. 5/6, p. 802, doi. 10.1038/sj.bjc.6690128
- By:
- Publication type:
- Article
Age-related decrease in cardiopulmonary adrenergic neuronal function in children as assessed by I-123 metaiodobenzylguanidine imaging
- Published in:
- Journal of Nuclear Cardiology, 2008, v. 15, n. 1, p. 73, doi. 10.1016/j.nuclcard.2007.09.027
- By:
- Publication type:
- Article
Criteria for evaluation of disease extent by (123)I-metaiodobenzylguanidine scans in neuroblastoma: a report for the International Neuroblastoma Risk Group (INRG) Task Force.
- Published in:
- 2010
- By:
- Publication type:
- journal article